8:00 |
Doors open
開場
|
8:30 - 8:35 |
Opening Remarks
開会挨拶
|
8:35 - 8:50 |
Agenda1 - Defining the 5th Conference; Re-recognizing the objectives
議題1 - 第五回会議の意義付け
Dr. Shigeru OMI, MD, PhD President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus, World Health Organization, Regional Office for Western Pacific
|
8:50 - 9:10 |
Keynote Speech
基調講演
Dr. Pedro ALONSO Director, Global Malaria Programme, World Health Organization
|
9:10 - 10:05 |
Agenda2-1 - Achievements of TB Consortium and its Future Challenges
議題2-①結核コンソーシアムの成果と課題
Moderator
Mr. Mitsuru MIYATA Executive Leader Writer, Nikkei Business Publications, Inc.
- Dr. Shigeru OMI, MD, PhD
President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus, World Health Organization, Regional Office for Western Pacific
- Kei KATSUNO, MD, MPH
Senior Director,
Investment Strategy & Government Relations Global Health Innovative Technology Fund (GHIT Fund)
- Dr. Seiya KATO
Director, The Research Institute of Tuberculosis Japan Anti-Tuberculosis Association
- Mr. Takato KOIZUMI
Deputy Counsellor Office for Pandemic Influenza Preparedness and Response, Coordination Office of Measures on Emerging Infectious Diseases, Cabinet Secretariat
- Dr. Junko SATO, PhD
Office Director, Office of International Cooperation, Pharmaceuticals and Medical Devices Agency (PMDA)
- Prof. Nikki SHINDO, MD, PhD
Manager, Expert Networks, WHO’s Health Emergency Programme (WHE) World Health Organization
- Manabu SUMI, MD, MPH, PhD
Director, Global Health Policy Division, Ministry of Foreign Affairs
- Mr. Kaoru TERASHIMA
Corporate Vice President, Medical System Business Division, In Vitro Diagnostics Division, FUJIFILM Corporation
- Kuniaki MIYAKE M.D.,M.S
Director, Tuberculosis and Infectious Diseases Control Division, Ministry of Health and Labor and Welfare, Japan (“MHLW”)
- Mr. Keiso YAMASAKI
Global Project Leader of TB Projects, Pharmaceutical Business Division,Otsuka Pharmaceutical Co., Ltd.
- Mr. Hiroshi YOSHIDA
Director, R&D, NIPRO CORPORATION
- Mr. Kozo WATANABE
Deputy Director General, and Group Director for Health 2, Human Development Department, Japan International Cooperation Agency
-
Mr. Hajime WATARI
Executive Officer, GM, Global Sales & Business Development EIKEN Chemical CO.,LTD.
- Vivi LISDAWATI, MSi, Apt., PhD.
Director of Research on Infectious & Communicable Diseases, Sulianti Saroso Infectious Diseases Hospital, MoH - Rep. of Indonesia
- MR. Celso Cachin MANANGAN
Project Director International Specialist Centre of Excellence for PPP in Health
|
10:15 - 11:10 |
Agenda2-2 - Overseas P3 Scheme on Ebola; Lessons Learned from Ebola Outbreak
議題2-②エボラ出血熱に関する海外における官民連携
Moderator
Mr. Mitsuru MIYATA Executive Leader Writer, Nikkei Business Publications, Inc.
- Dr. Kazunari ASANUMA, MD, PhD
Assistant Director-General for Health Sciences, Minister’s Secretariat, Ministry of Health, Labour and Welfare
- Dr. Shigeru OMI, MD, PhD
President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus, World Health Organization, Regional Office for Western Pacific
- Mr. Yoshikatsu OBU
Counsellor Office for Pandemic Influenza Preparedness and Response / Coordination Office of Measures on Emerging Infectious Diseases, Cabinet Secretariat
- Mr. Hiroaki GOTO
General Manager, Molecular Testing Solutions Business Development Dept. Canon Medical Systems Corporation
- Dr. Tatsuya KONDO
Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA)
- Prof. Kimiyasu SHIRAKI, MD, PhD
Professor and Chairman Department of Virology, University of Toyama
- Prof. Nikki SHINDO, MD, PhD
Manager, Expert Networks, WHO’s Health Emergency Programme (WHE) World Health Organization
- Manabu SUMI, MD, MPH, PhD
Director, Global Health Policy Division, Ministry of Foreign Affairs
- Mr. Koichi YAMADA
Director, General Manager, Business Development Dept. Toyama Chemical Co.,LTd.
- Prof. Jiro YASUDA PhD, DVM
Director, National Research Center for the Control and Prevention of Infectious Diseases (CCPID) & Professor, Institute of Tropical Medicine (NEKKEN), Nagasaki University
|
11:20 - 12:20 |
Lunch Session-1 - Japan China Korea PDPs Collaboration in Emerging Infectious Diseases Countermeasures: A Case of SFTS
ランチセッション① 新興感染症に対する日中韓産官学の取り組み ~重症熱性血小板減少症候群(Severe Fever with Thrombocytopenia Syndrome :SFTS)の事例から~
Moderator
Mr. Yasuhide YAMADA Former Director-General of Coordination Office of Measures on Emerging Infectious Diseases and Office for Pandemic Influenza Preparedness and Response, Cabinet Secretariat
- Masayuki SAIJO , MD, PhD
Director, Department of Virology 1, National Institute of Infectious Diseases
- Dr. Junko SATO, PhD
Office Director, Office of International Cooperation, Pharmaceuticals and Medical Devices Agency (PMDA)
- Mr. Koichi YAMADA
Director, General Manager, Business Development Dept. Toyama Chemical Co.,LTd.
- Prof. Dr. Masaki YASUKAWA, MD, PhD
Professor, Departmnet of Hematology, Clinical Immunology, and Infectious Diseases, Ehime University Graduate School of Medicine
|
12:30 - 13:25 |
Agenda2-3 - Achievements of Malaria Consortium and its Future Challenges
議題2-③マラリアコンソーシアムの成果と課題
Moderator
Prof. Kiyoshi KITA Dean and Professor, School of Tropical Medicine and Global Health, Nagasaki University
- Dr. Kinya UCHIHASHI, PhD
Vice President, Cell Technology Engineering 1, Sysmex Corporation
- Dr. Shigeru OMI, MD, PhD
President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus, World Health Organization, Regional Office for Western Pacific
- Dr. Kaname KANAI, MD, Ph.D.
Human Development Department / Exective Technical Advisor, Japan International Cooperation Agency
- Prof. Akira KANEKO, MD, PhD, DTM&H
Professor, Department of Parasitology, Osaka City University Graduate School of Medicine
- Prof. Dr. Shigeyuki KANO , MD, PhD
Director, Department of Tropical Medicine and Malaria National Center for Global Health and Medicine, Research Institute
- Mr. Satofumi KAWATA
Representative Director, neopharma Japan Co., Ltd.
- Mr. Takato KOIZUMI
Deputy Counsellor Office for Pandemic Influenza Preparedness and Response, Coordination Office of Measures on Emerging Infectious Diseases, Cabinet Secretariat
- Prof. Nikki SHINDO, MD, PhD
Manager, Expert Networks, WHO’s Health Emergency Programme (WHE) World Health Organization
- Manabu SUMI, MD, MPH, PhD
Director, Global Health Policy Division, Ministry of Foreign Affairs
- Prof. Takafumi TSUBOI, MD, PhD
Director, Proteo-Science Center, Ehime University
- Mr. Ray NISHIMOTO
Representative Director & Senior Managing Executive Officer, Sumitomo Chemical Company, Limited
- Prof. Toshihiro HORII, PhD
Professor, Research Center for Infectious Disease Control, Research Institute for Microbial Diseases, Osaka University
- Kuniaki MIYAKE M.D.,M.S
Director, Tuberculosis and Infectious Diseases Control Division, Ministry of Health and Labor and Welfare, Japan (“MHLW”)
- Mr. Mitsuru MIYATA
Executive Leader Writer, Nikkei Business Publications, Inc.
- Ms. Keiko WATANABE
Marketing Department MKT4-1 EIKEN CHEMICAL Co.,Ltd.
- Dr. Pedro ALONSO
Director, Global Malaria Programme, World Health Organization
- Mrs. Valentina BUJ de Lauwerier
Global Malaria and Health Partnerships Advisor UNICEF
- Assoc. Prof. Pratap SINGHASIVANON, MD.
Dean, Faculty of Tropical Medicine, Mahidol University
- Dr. BT SLINGSBY, MD, PhD, MPH
CEO & Executive Director Global Health Innovative Technology Fund (GHIT Fund)
|
13:35 - 14:30 |
Agenda2-4 - Approaches towards AMR
議題2-④薬剤耐性(AMR)への取り組み
Moderator
Dr. Kazunari ASANUMA, MD, PhD Assistant Director-General for Health Sciences, Minister’s Secretariat,
Ministry of Health, Labour and Welfare
- Dr. Shigeru OMI, MD, PhD
President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus, World Health Organization, Regional Office for Western Pacific
- Prof. Dr. Shigeyuki KANO , MD, PhD
Director, Department of Tropical Medicine and Malaria National Center for Global Health and Medicine, Research Institute
- Toru Kimura, Ph.D.
Member, Board of Directors Executive Officer, Sumitomo Dainippon Pharma Co., Ltd.
- Mr. Michikazu KOSHIBA
Head, Center on Global Health Architecture/ Senior Manager, Business Creation Office, Corporate Planning Dept. MITSUBISHI UFJ RESEARCH AND CONSULTING CO., LTD.
- Dr. Junko SATO, PhD
Office Director, Office of International Cooperation, Pharmaceuticals and Medical Devices Agency (PMDA)
- Ms. Takuko SAWADA
Director of the Board, Senior Executive Officer, Senior Vice President, Corporate Strategy Division, Shionogi & Co., Ltd.
- Mr. Yusuke SARAYA
President, Saraya Co., Ltd.
- Prof. Nikki SHINDO, MD, PhD
Manager, Expert Networks, WHO’s Health Emergency Programme (WHE) World Health Organization
- Mr.Chikara TSUKAMOTO
Cabinet Secretariat, Councillor,Director General of Coordination Office of Measures on Emerging Infectious Diseases and Office for Pandemic Influenza Preparedness and Responses
- Mitsuru TODA, MS, PhD
Epidemic Intelligence Service (EIS) Officer, Mycotic Diseases Branch, National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), Centers for Disease Control and Prevention (CDC)
- Director. Dr. Hideaki HANAKI, Ph, PhD
Director, Infection Control Research Center, Kitasato University
- Dr. Kazuki HOSHINO, PhD
R&D Planning & Management Department, Kitasato Daiichi Sankyo Vaccine Co., Ltd.
- Prof. Satoshi MITARAI MD, Ph.D.
Head, Dept. of Mycobacterium Reference and Research Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association
- Kuniaki MIYAKE M.D.,M.S
Director, Tuberculosis and Infectious Diseases Control Division, Ministry of Health and Labor and Welfare, Japan (“MHLW”)
- Mr. Mitsuru MIYATA
Executive Leader Writer, Nikkei Business Publications, Inc.
- Dr. Yasuhiro YASUTOMI, DVM, PhD
Director, Tsukuba Primate Research Center, National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN)
Professor, Division of Immunoregulation, Department of Molecular and Experimental Medecine, Mie University Graduate School of Medicine
- Mr. Hiroshi YOSHIDA
Director, R&D, NIPRO CORPORATION
- Dr. Trinh Hong SON
Reseacher. Director of Center for Nutrition Information, Education and Communication (NIEC), National Institute of Nutrition (NIN)
- Dr. Peter JACKSON
Executive Director, The AMR Centre
- Dr. Jean-Pierre PACCAUD, PhD
Director of Business Development and Corporate Strategy, Global Antibiotic R&D Partnership (GARDP)
|
14:40 - 15:35 |
Agenda3-1 - Establishment of “Asian Communicable Diseases Clinical Research Center”, and the Role of Okinawa in the Concept
議題3-①アジアにおける感染症臨床試験センターおよび沖縄感染症研究拠点の構築
Moderator①
Dr. Yasuhiro YASUTOMI, DVM, PhD Director, Tsukuba Primate Research Center, National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN) Professor, Division of Immunoregulation, Department of Molecular and Experimental Medecine, Mie University Graduate School of Medicine
Moderator②
Prof. Jiro FUJITA, MD, PhD, FCCP Director, University of the Ryukyus Hospital
- Tatsuo IIYAMA, M.D.
Chief manager of the Department of International Trial, Center for Clinical Sciences, National Center for Global Health and Medicine (NCGM)
- Dr. Hitoshi OINUMA, PhD
Senior Vice President, Head of Japan Vaccine Business Unit, Takeda Pharmaceutical Company Limited
- Prof. Hitoshi OSHITANI, MD, PhD, MPH
Professor, Medicine Department of Virology, Tohoku University Graduate School
- Dr. Shigeru OMI, MD, PhD
President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus, World Health Organization, Regional Office for Western Pacific
- Mr. Noboru KAKAZU
Deputy Director General in charge of Planning Promotion Department of Planning Okinawa Prefectural Government
- Prof. Dr. Shigeyuki KANO , MD, PhD
Director, Department of Tropical Medicine and Malaria National Center for Global Health and Medicine, Research Institute
- Dr. Tatsuya KONDO
Chief Executive, Pharmaceuticals and Medical Devices Agency (PMDA)
- Prof. Nikki SHINDO, MD, PhD
Manager, Expert Networks, WHO’s Health Emergency Programme (WHE) World Health Organization
- Mr.Chikara TSUKAMOTO
Cabinet Secretariat, Councillor,Director General of Coordination Office of Measures on Emerging Infectious Diseases and Office for Pandemic Influenza Preparedness and Responses
- Director. Dr. Hideaki HANAKI, Ph, PhD
Director, Infection Control Research Center, Kitasato University
- Prof. Kenji HIRAYAMA, MD. Ph.D.
Dean, Institute of Tropical Medicine, Nagasaki Univerisity
- Kuniaki MIYAKE M.D.,M.S
Director, Tuberculosis and Infectious Diseases Control Division, Ministry of Health and Labor and Welfare, Japan (“MHLW”)
- Mr. Mitsuru MIYATA
Executive Leader Writer, Nikkei Business Publications, Inc.
- Dr. Yoshinori YAMANO, Ph.D.
Chief Scientific Officer for Infectious Diseases, Pharmaceutical Research Division, SHIONOGI & CO., LTD.
- Mr. Kozo WATANABE
Deputy Director General, and Group Director for Health 2, Human Development Department, Japan International Cooperation Agency
- Vivi LISDAWATI, MSi, Apt., PhD.
Director of Research on Infectious & Communicable Diseases, Sulianti Saroso Infectious Diseases Hospital, MoH - Rep. of Indonesia
- Prof. Dr. Suchinda MALAIVIJITNOND, Ph.D.
Professor at Chulalongkorn University, and Director of the National Primate Research Center of Thailand-Chulalongkorn University (NPRCT-CU)
- MR. Celso Cachin MANANGAN
Project Director International Specialist Centre of Excellence for PPP in Health
- Assoc. Prof. Pratap SINGHASIVANON, MD.
Dean, Faculty of Tropical Medicine, Mahidol University
|
15:45 - 16:40 |
Agenda3-2 - Public Hygiene
議題3-②公衆衛生
Moderator
Prof. Hitoshi OSHITANI, MD, PhD, MPH Professor, Medicine Department of Virology,
Tohoku University Graduate School
- Toru ITOKAZU,MD,MPH
Deputy Director General in charge of health and sanitation, Okinawa Prefectural Government
- Dr. Shigeru OMI, MD, PhD
President of JAPAN Community Health care Organization (JCHO) Regional Director Emeritus, World Health Organization, Regional Office for Western Pacific
- Prof. Dr. Tatsuo OMURA
New Industry Creation Hatchery Center, Professor Tohoku University
- Mr. Michikazu KOSHIBA
Head, Center on Global Health Architecture/ Senior Manager, Business Creation Office, Corporate Planning Dept. MITSUBISHI UFJ RESEARCH AND CONSULTING CO., LTD.
- Prof. Jun KOBAYASHI MD PhD
Professor School of Health Siences, Faculty of Medicine, University of the Ryukyus
- Mr. Yusuke SARAYA
President, Saraya Co., Ltd.
- Prof. Nikki SHINDO, MD, PhD
Manager, Expert Networks, WHO’s Health Emergency Programme (WHE) World Health Organization
- Manabu SUMI, MD, MPH, PhD
Director, Global Health Policy Division, Ministry of Foreign Affairs
- Mr. Takemasa MAMIYA
Executive Managing Director and Board Member Global Headquarters Nihon Suido Consultants Co., Ltd.
- Mr. Mitsuru MIYATA
Executive Leader Writer, Nikkei Business Publications, Inc.
- Mr. Kozo WATANABE
Deputy Director General, and Group Director for Health 2, Human Development Department, Japan International Cooperation Agency
- Dr. Mark SALTER MBBS, MSc, PhD, MFPHM
Consultant in Global Health and Communicable Disease Control Public Health England
- Dr. Trinh HONG Son
Reseacher. Director of Center for Nutrition Information, Education and Communication (NIEC), National Institute of Nutrition (NIN)
|
|
Breakout Session A 分科会A |
Breakout Session B 分科会B |
Breakout Session C 分科会C |
16:50 - 17:45 |
A-1
Saraya
Hand Hygiene for IPC (Infection Prevention and Control) against AMR(Tentative Proposal) ~Intervention with ABHR to the AMR issues: focus on ESBL producing bacteria in Vietnam~
AMRに立ち向かおう!HAND HYGIENEアプローチの可能性
Moderator
Mr. Michikazu KOSHIBA
Head, Center on Global Health Architecture/ Senior Manager, Business Creation Office, Corporate Planning Dept. MITSUBISHI UFJ RESEARCH AND CONSULTING CO., LTD.
- Mr. Yusuke SARAYA
President, Saraya Co., Ltd.
- Jun MORIYAMA, RN MSN
National Center for Global Health and Medicine Bureau of International Health Cooperation JICA Project for Improvement of Hospital Management Competency(Patient Safety, Nursing Management)
- Mr. Kozo WATANABE
Deputy Director General, and Group Director for Health 2, Human Development Department, Japan International Cooperation Agency
- Dr. Trinh HONG Son
Reseacher. Director of Center for Nutrition Information, Education and Communication (NIEC), National Institute of Nutrition (NIN)
|
B-1
SHIONOGI
Issues and Actions to Combat Influenza Virus Infection
インフルエンザウイルス感染症対策の現状と課題
Moderator
Prof. Yoshihiro KAWAOKA DVM, PhD
Department of Microbiology and immunology, Professor
University of Tokyo, Institute of Medical Science
- Mr. Yoshikatsu OBU
Counsellor Office for Pandemic Influenza Preparedness and Response / Coordination Office of Measures on Emerging Infectious Diseases, Cabinet Secretariat
- Dr. Akira NAITO, PhD
Department Head of Infectious Diseases, Drug Discovery & Disease Research Laboratory, Shionogi & Co. Ltd.
- Prof. Jiro FUJITA, MD, PhD, FCCP
Director, University of the Ryukyus Hospital
- Mr. Hiroshi YOSHIDA
Director, R&D, NIPRO CORPORATION
- Vivi LISDAWATI, MSi, Apt., PhD.
Director of Research on Infectious & Communicable Diseases, Sulianti Saroso Infectious Diseases Hospital, MoH - Rep. of Indonesia
|
C-1
SYSMEX
WHO's goal for Malaria Elimination ~Contribution of new diagnostic technologies~
WHOの目指すマラリアエリミネーション -新たな診断技術の貢献-
Moderator
Prof. Kiyoshi KITA
Dean and Professor, School of Tropical Medicine and Global Health, Nagasaki University
- Dr. Kinya UCHIHASHI, PhD
Vice President, Cell Technology Engineering 1, Sysmex Corporation
- Prof. Dr. Shigeyuki KANO , MD, PhD
Director, Department of Tropical Medicine and Malaria National Center for Global Health and Medicine, Research Institute
- Tomomi KITAMURA, MD, MSc
Deputy director, The Office for Global Strategy of Medical Service and Health Industry, General Affairs Division, Health Policy Bureau Ministry of Health, Labour, and Welfare
- Ms. Keiko WATANABE
Marketing Department MKT4-1 EIKEN CHEMICAL Co.,Ltd.
- Dr. Pedro ALONSO
Director, Global Malaria Programme, World Health Organization
- Assoc. Prof. Pratap SINGHASIVANON, MD.
Dean, Faculty of Tropical Medicine, Mahidol University
|
17:50 - 18:45 |
A-2
Okinawa Prefecture
Efforts and prospects towards a center of excellence on communicable diseases research in Okinawa. 沖縄感染症研究拠点形成に向けた取組と展望
Moderator
Prof. Jiro FUJITA, MD, PhD, FCCP
Director, University of the Ryukyus Hospital
- Mr. Noboru KAKAZU
Deputy Director General in charge of Planning Promotion Department of Planning Okinawa Prefectural Government
- Dr. Tomimasa SUNAGAWA, MD, PhD
Division Chief / Infectious Disease Surveillance Center National Institute of Infectious Diseases, Japan
- Dr. Yoshihiro TAKAYAMA , MD
Division of Infectious Diseases / chief physician Okinawa Chubu Hospital
- Mr. Munesada YAMAKAWA
Department of Public Health and Medical Care , Regional Public Health Division / Director Okinawa Prefectural Government
- Professor Tetsu YAMASHIRO, MD., PhD
Department of Bacteriology, Professor Graduate School of Medicine, University of the Ryukyus
|
B-2
DAIICHI SANKYO
Unmet needs in prevention and treatment of infectious diseases in Asian countries and sustainable contribution by industries
アジアにおける感染症予防薬・治療薬のニーズと企業による貢献
Moderator
Mr. Mitsuru MIYATA
Executive Leader Writer, Nikkei Business Publications, Inc.
- Dr. Kazunari ASANUMA, MD, PhD
Assistant Director-General for Health Sciences, Minister’s Secretariat, Ministry of Health, Labour and Welfare
- Tatsuo IIYAMA, M.D.
Chief manager of the Department of International Trial, Center for Clinical Sciences, National Center for Global Health and Medicine (NCGM)
- Norihito UEDA, MD, PhD
Vice President, Vaccine Oversight Department, Daiichi Sankyo Co., Ltd.
- Mr. Takato KOIZUMI
Deputy Counsellor Office for Pandemic Influenza Preparedness and Response, Coordination Office of Measures on Emerging Infectious Diseases, Cabinet Secretariat
- Dr. Junko SATO, PhD
Office Director, Office of International Cooperation, Pharmaceuticals and Medical Devices Agency (PMDA)
- Dr.Akihiko FUJIE, PhD
Science Coordinator, iD3(Department of Innovative Drug Discovery and Development), Division of Strategic Planning and Evaluation, AMED (Japan Agency for Medical Research and Development)
- Eiichi YAMAGUCHI, Ph.D.
Executive member, International Affairs Committee Japan Pharmaceutical Manufacturers Association
- Prof. Dr. Suchinda MALAIVIJITNOND, Ph.D.
Professor at Chulalongkorn University, and Director of the National Primate Research Center of Thailand-Chulalongkorn University (NPRCT-CU)
- Dr. Jean-Pierre PACCAUD, PhD
Director of Business Development and Corporate Strategy, Global Antibiotic R&D Partnership (GARDP)
|
C-2
Sumitomo Chemical
Vector Control - current status and challenges in Asia and Africa
アジア、アフリカにおけるベクターコントロールの現状と課題
Moderator
Prof. Noboru MINAKAWA PhD
Professor, Institute of Tropical Medicine, Nagasaki University
- Mr. Ray NISHIMOTO
Representative Director & Senior Managing Executive Officer, Sumitomo Chemical Company, Limited
- Mr. Tatsuo MIZUNO
Executive Director, Malaria No More Japan
- Dr. Pedro ALONSO
Director, Global Malaria Programme, World Health Organization
- Mr. Patrik SILBORN
Senior Director Resource Mobilization Asia Pacific Leaders Malaria Alliance (APLMA)
|